VANGUARD GROUP INC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$19,095,902
-48.0%
8,195,666
-0.1%
0.00%
-100.0%
Q1 2024$36,687,811
+26.6%
8,207,564
-9.1%
0.00%0.0%
Q4 2023$28,988,948
-13.6%
9,030,825
-14.7%
0.00%0.0%
Q3 2023$33,563,338
-10.0%
10,587,804
+41.1%
0.00%0.0%
Q2 2023$37,282,420
+3.3%
7,501,493
+2.7%
0.00%0.0%
Q1 2023$36,088,360
-21.0%
7,305,336
+0.6%
0.00%0.0%
Q4 2022$45,698,239
-40.9%
7,265,221
+1.4%
0.00%
-50.0%
Q3 2022$77,362,000
-19.3%
7,163,082
-14.8%
0.00%
-33.3%
Q2 2022$95,830,000
+55.7%
8,406,147
+24.5%
0.00%
+200.0%
Q1 2022$61,529,000
-38.8%
6,753,980
+0.2%
0.00%
-50.0%
Q4 2021$100,588,000
-41.5%
6,741,839
+0.7%
0.00%
-50.0%
Q3 2021$172,080,000
-0.1%
6,695,720
+1.4%
0.00%0.0%
Q2 2021$172,189,000
-18.1%
6,602,306
+10.8%
0.00%
-33.3%
Q1 2021$210,271,000
+44.0%
5,956,693
+2.9%
0.01%
+50.0%
Q4 2020$146,051,000
-31.5%
5,786,477
+2.3%
0.00%
-42.9%
Q3 2020$213,333,000
-15.3%
5,657,203
-3.8%
0.01%
-22.2%
Q2 2020$251,839,000
+216.0%
5,881,314
+43.5%
0.01%
+200.0%
Q1 2020$79,694,000
-22.3%
4,099,451
+3.8%
0.00%0.0%
Q4 2019$102,577,000
-4.7%
3,948,293
+0.0%
0.00%
-25.0%
Q3 2019$107,597,000
+16.4%
3,947,770
+14.7%
0.00%
+33.3%
Q2 2019$92,449,000
+52.3%
3,443,180
+64.0%
0.00%
+50.0%
Q1 2019$60,703,000
+10.2%
2,099,721
+2.6%
0.00%0.0%
Q4 2018$55,107,0002,046,3290.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders